1. Home
  2. BLLN vs BIPC Comparison

BLLN vs BIPC Comparison

Compare BLLN & BIPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$97.95

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Brookfield Infrastructure Corporation

BIPC

Brookfield Infrastructure Corporation

HOLD

Current Price

$38.68

Market Cap

4.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
BIPC
Founded
2016
2019
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BLLN
BIPC
Price
$97.95
$38.68
Analyst Decision
Buy
Sell
Analyst Count
7
1
Target Price
$126.71
$45.00
AVG Volume (30 Days)
784.7K
1.1M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
5.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$46.29
$7.85
Revenue Next Year
$30.14
$5.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$61.96
$34.18
52 Week High
$150.44
$51.72

Technical Indicators

Market Signals
Indicator
BLLN
BIPC
Relative Strength Index (RSI) 37.20 36.93
Support Level $73.46 $37.42
Resistance Level $108.50 $42.84
Average True Range (ATR) 8.11 1.44
MACD -5.35 -0.34
Stochastic Oscillator 15.41 2.31

Price Performance

Historical Comparison
BLLN
BIPC

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About BIPC Brookfield Infrastructure Corporation

Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom, United States, France, Switzerland, Singapore, China, Denmark, Hong Kong, Germany and Others.

Share on Social Networks: